Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors.
Zekun LiZhenping ChenGuoqing LiuXiaoling ChengWanru YaoHuang KunGang LiYingzi ZhenXinyi WuSiyu CaiMan-Chiu PoonRunhui WuPublished in: Research and practice in thrombosis and haemostasis (2021)
The use of low-dose ITI with or without immunosuppressants according to ITI prognostic risk(s) is a clinically and economically feasible strategy for eradicating inhibitors in children with HA, particularly for those with historic peak inhibitor titer <100 BU.